午夜插插,噜噜噜影院,啪啪伊人网,欧美熟夫,景甜吻戏视频,男人强操性感蕾丝美女视频在线网站,日本美女跳舞视频

Welcome to chemicalbook!
+1 (818) 612-2111
Inquriy
Try our best to find the right business for you.
Do not miss inquiry messages Please log in to view all inquiry messages.

Welcome back!

RFQ
skype
MY Account
Top
Postion:Product Catalog >FEXUPRAZAN HCL
FEXUPRAZAN HCL
  • FEXUPRAZAN HCL
  • FEXUPRAZAN HCL
  • FEXUPRAZAN HCL

FEXUPRAZAN HCL

Price Get Latest Price
Package 1g 10g
Min. Order: 1g
Supply Ability: 5kg
Update Time: 2025-03-04

Product Details

Product Name: FEXUPRAZAN HCL CAS No.: 1902954-87-3
Min. Order: 1g Purity: 0.99
Supply Ability: 5kg Release date: 2025/03/04

?Fexuprazan Hydrochloride (CAS 1902954-87-3) | High-Purity Potassium-Competitive Acid Blocker (P-CAB)? ?


?? ?Product Overview?

?Fexuprazan Hydrochloride? (CAS 1902954-87-3), also known as ?Abeprazan HCl?, is a potent ?potassium-competitive acid blocker? (P-CAB) with the molecular formula ?C??H??ClF?N?O?S? and a molecular weight of ?446.87?. This white to light-yellow crystalline powder (purity ≥98%) is designed for ?acid-related gastrointestinal disorder treatment?, offering rapid and sustained suppression of gastric acid secretion. It acts by inhibiting H+/K+-ATPase in gastric parietal cells, making it a superior alternative to traditional proton pump inhibitors (PPIs) with faster onset and longer duration.

?Key Functions?:

  • Treats gastroesophageal reflux disease (GERD) and peptic ulcers.

  • Enhances Helicobacter pylori eradication therapy efficacy.

  • Serves as a pharmaceutical intermediate for advanced formulations.

?Target Industries?: Pharmaceutical manufacturing, clinical research, and biotechnology.


?Key Advantages?

?? ?Ultra-High Purity??? ?Flexible Packaging??? ?Stability?
≥98% HPLC/EP-certified1g to 25kg bulk optionsStable at -20°C, moisture-proof
Batch-specific COATamper-evident packaging24-month shelf life

?? ?Applications?

  • ?GERD Management?: Oral tablets or capsules for chronic acid reflux relief.

  • ?Peptic Ulcer Therapy?: Combined with antibiotics for H. pylori eradication.

  • ?Drug Development?: Intermediate for novel P-CAB formulations and bioavailability studies.


?? ?Quality Assurance?

  • ?Testing Standards?: Complies with ?USP/EP? pharmacopeial guidelines.

  • ?Analytical Validation?: HPLC, NMR, and LC-MS for identity and impurity profiling.

  • ?Certifications?: ISO 9001 and GMP compliance for pharmaceutical-grade production.


?? ?Market Insights?

The global GERD treatment market is projected to reach ?$6.8 billion by 2030?, driven by rising prevalence of acid-related disorders and demand for non-PPI therapies. Fexuprazan is gaining traction in ?Asia-Pacific? due to cost-effective manufacturing and expanding healthcare infrastructure.

Article illustration

Article illustration

Article illustration


Company Profile Introduction

Wuhan Biocar Pharmaceutical Co., Ltd. is a high-tech and innovative enterprise specializing in the research, development, production, and sales of APIs and pharmaceutical intermediates (excluding finished drugs). Located in the heart of Optics Valley Biological City, our company leverages the cutting-edge facilities of the Wuhan University Scientific Research Laboratory and benefits from the region's favorable policies to advance the field of biomedicine. Guided by our business philosophy—"Driven by market demand, powered by technological innovation, and enabled by e-commerce"—we are committed to delivering biomedical products that are precise, high-quality, fast, and reliable. Our offerings serve pharmaceutical companies, university research institutions, hospital outpatient services, reagent providers, and distributors worldwide.

You may like

Recommended supplier

Product name Price   Suppliers Update time
$400.00/1kg
VIP1Y
Hebei Junhua Import and Export Co., LTD
2025-02-19
$94.00/1mg
VIP3Y
TargetMol Chemicals Inc.
2024-11-01
$94.00/1mg
VIP5Y
TargetMol Chemicals Inc.
2024-11-01
  • Since: 2018-06-08
  • Address: Biolake.858 high-tech avenue,Wuhan
INQUIRY

+86-+undefined-+86 13343427080
sales@biocarchem.com